AP23573
Term · Oncology and biomedicine · MLC-T-ONC-000672
A substance being studied in the treatment of soft tissue and bone cancers. It is also being studied in the treatment of other solid tumors and hematologic cancer. AP23573 stops cells from dividing and may cause cancer cells to die. It is a type of mTOR inhibitor. Also called ridaforolimus.
| Identifier | MLC-T-ONC-000672 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | ridaforolimus |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000672",
"term": "AP23573",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of soft tissue and bone cancers. It is also being studied in the treatment of other solid tumors and hematologic cancer. AP23573 stops cells from dividing and may cause cancer cells to die. It is a type of mTOR inhibitor. Also called ridaforolimus.",
"expansions": [
"ridaforolimus"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/ap23573/"
}
Record 2,354 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.